JP4197180B2 - 検体中の内分泌物質測定方法 - Google Patents

検体中の内分泌物質測定方法 Download PDF

Info

Publication number
JP4197180B2
JP4197180B2 JP2005190003A JP2005190003A JP4197180B2 JP 4197180 B2 JP4197180 B2 JP 4197180B2 JP 2005190003 A JP2005190003 A JP 2005190003A JP 2005190003 A JP2005190003 A JP 2005190003A JP 4197180 B2 JP4197180 B2 JP 4197180B2
Authority
JP
Japan
Prior art keywords
insulin
endocrine
feline
cat
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2005190003A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007010418A (ja
JP2007010418A5 (enExample
Inventor
正章 小島
達之 蜂巣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FUJIFILM Wako Shibayagi Corporation
Original Assignee
FUJIFILM Wako Shibayagi Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2005190003A priority Critical patent/JP4197180B2/ja
Application filed by FUJIFILM Wako Shibayagi Corporation filed Critical FUJIFILM Wako Shibayagi Corporation
Priority to EP05809384A priority patent/EP1898215B1/en
Priority to PCT/JP2005/021443 priority patent/WO2007000832A1/ja
Priority to US11/988,063 priority patent/US8058011B2/en
Priority to DE602005025940T priority patent/DE602005025940D1/de
Priority to AT05809384T priority patent/ATE495441T1/de
Publication of JP2007010418A publication Critical patent/JP2007010418A/ja
Publication of JP2007010418A5 publication Critical patent/JP2007010418A5/ja
Application granted granted Critical
Publication of JP4197180B2 publication Critical patent/JP4197180B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2005190003A 2005-06-29 2005-06-29 検体中の内分泌物質測定方法 Expired - Fee Related JP4197180B2 (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2005190003A JP4197180B2 (ja) 2005-06-29 2005-06-29 検体中の内分泌物質測定方法
PCT/JP2005/021443 WO2007000832A1 (ja) 2005-06-29 2005-11-22 検体中の内分泌物質測定方法。
US11/988,063 US8058011B2 (en) 2005-06-29 2005-11-22 Method for the measurement of endocrine substances in an analyte
DE602005025940T DE602005025940D1 (de) 2005-06-29 2005-11-22 Verfahren zum testen endokriner substanz in proben
EP05809384A EP1898215B1 (en) 2005-06-29 2005-11-22 Method of assaying endocrine substance in specimen
AT05809384T ATE495441T1 (de) 2005-06-29 2005-11-22 Verfahren zum testen endokriner substanz in proben

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005190003A JP4197180B2 (ja) 2005-06-29 2005-06-29 検体中の内分泌物質測定方法

Publications (3)

Publication Number Publication Date
JP2007010418A JP2007010418A (ja) 2007-01-18
JP2007010418A5 JP2007010418A5 (enExample) 2008-04-24
JP4197180B2 true JP4197180B2 (ja) 2008-12-17

Family

ID=37595091

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005190003A Expired - Fee Related JP4197180B2 (ja) 2005-06-29 2005-06-29 検体中の内分泌物質測定方法

Country Status (6)

Country Link
US (1) US8058011B2 (enExample)
EP (1) EP1898215B1 (enExample)
JP (1) JP4197180B2 (enExample)
AT (1) ATE495441T1 (enExample)
DE (1) DE602005025940D1 (enExample)
WO (1) WO2007000832A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5413766B2 (ja) * 2008-03-10 2014-02-12 株式会社シバヤギ レプチン測定方法
US20110136141A1 (en) * 2009-12-03 2011-06-09 Abbott Laboratories Peptide reagents and method for inhibiting autoantibody antigen binding
JP5504945B2 (ja) * 2010-02-12 2014-05-28 日東紡績株式会社 Ｆｔｃｄとその自己抗体との複合体の免疫測定方法、それに用いるキット及びそれを用いた癌判定方法
EP3362793B1 (en) * 2015-10-15 2019-08-28 Biocon Limited Method for detecting neutralizing antibodies against recombinant human insulin in human serum
CN109477832A (zh) * 2016-09-06 2019-03-15 富士瑞必欧株式会社 甲状腺球蛋白的测定方法及测定试剂
JP6999561B2 (ja) * 2016-09-13 2022-02-10 富士レビオ株式会社 心筋トロポニンの測定方法及び測定試薬
WO2018212221A1 (ja) * 2017-05-17 2018-11-22 富士レビオ株式会社 インスリンの測定方法及び測定試薬
US12297227B2 (en) 2017-06-02 2025-05-13 Mediford Corporation Method for extracting target protein from biological sample and method for analyzing target protein
EP3978921A4 (en) * 2019-05-24 2023-05-24 Fujirebio Inc. METHOD AND SYSTEM FOR MEASUREMENT OF THYREOGLOBULIN
CN111077323A (zh) * 2020-01-12 2020-04-28 天津市宝坻区人民医院 消除胰岛素自身抗体干扰的胰岛素测定试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855242A (en) * 1986-04-14 1989-08-08 Joslin Diabetes Center, Inc. Method of detecting antibodies
JPH0291572A (ja) 1988-09-08 1990-03-30 Nippon Dpc Corp ウァルスｄｎａを用いた生物学的液体中の抗ｄｎａ抗体価の測定法および測定用キット
JPH03134567A (ja) 1989-10-19 1991-06-07 Yamasa Shoyu Co Ltd 抗リン脂質抗体結合用担体、それを使用する免疫学的測定法およびキット
JP2789306B2 (ja) * 1994-11-15 1998-08-20 株式会社第一ラジオアイソトープ研究所 インスリン様成長因子の免疫学的測定方法ならびにインスリン様成長因子測定用キット
JPH11326322A (ja) 1998-05-06 1999-11-26 Shibayagi:Kk イヌインスリン測定用キットおよびそれを用いたイヌインスリン測定方法
JP3740898B2 (ja) * 1998-07-31 2006-02-01 三菱化学株式会社 生理活性成分の測定法
DE69929059T2 (de) * 1998-07-31 2006-08-24 Mitsubishi Chemical Corp. Verfahren zum bestimmen von physiologisch aktiven komponenten
WO2003016575A1 (en) * 2001-08-17 2003-02-27 Luminex Corporation Method for characterizing autoimmune disorders
US20050026826A1 (en) * 2003-01-17 2005-02-03 Margarethe Hoenig Feline proinsulin, insulin and constituent peptides

Also Published As

Publication number Publication date
JP2007010418A (ja) 2007-01-18
ATE495441T1 (de) 2011-01-15
DE602005025940D1 (de) 2011-02-24
US20090176252A1 (en) 2009-07-09
US8058011B2 (en) 2011-11-15
WO2007000832A1 (ja) 2007-01-04
EP1898215A4 (en) 2008-11-05
EP1898215A1 (en) 2008-03-12
EP1898215B1 (en) 2011-01-12

Similar Documents

Publication Publication Date Title
JP4968611B2 (ja) 免疫抑制剤の改善された測定法
TWI704348B (zh) 腎疾病之檢查方法
WO1994017408A1 (en) Assays and kits for detecting analytes in the presence of cross-reacting substances
US20070059682A1 (en) Method to increase specificity and/or accuracy of lateral flow immunoassays
CN102421799B (zh) 用于高分子脂联素分析的新型单克隆抗体及其应用
JP4197180B2 (ja) 検体中の内分泌物質測定方法
JP2002530651A (ja) 生物学的試料中のアナライトの存在を検出する方法
Song et al. Chip-based cartilage oligomeric matrix protein detection in serum and synovial fluid for osteoarthritis diagnosis
JP2023017986A (ja) 自己抗体の直接イムノアッセイ測定法
CN114047343B (zh) 双耐受型抗IgE单抗药物的免疫原性分析试剂盒及其使用方法和应用
JP4197393B2 (ja) ＩｇＡ腎症の検査法
JP7304649B2 (ja) スイッチ性付着反応を用いた親和分離システム及び方法
GB2120785A (en) Enzyme immunoassay
WO2017055597A1 (en) Method to detect blood creatinine and an immunosuppressive drug
JPH08304406A (ja) カリブレーターマトリックス
CN109991428A (zh) 一种经过封闭处理的双抗原夹心间接法
JP3171681B2 (ja) 糖化蛋白の測定方法
WO2021146776A1 (en) Detecting gut barrier dysfunction and/or cirrhosis
WO2025182761A1 (ja) Ｇｆａｐの検出方法、アルツハイマー病の診断を補助する方法、及びそれらに用いるキット
LU100002B1 (en) New testing device and method for detecting Ankylosing Spondylitis
US20150338399A1 (en) Methods for diagnosing and monitoring disease by directly quantifying disease modified biomolecules
JP4505800B2 (ja) 抗腎タイプｉｖモノクロ−ナル抗体
WO2013144615A1 (en) Biological reagent
Gonzalez et al. Development of a fibrinogen-specific sandwich enzyme-linked immunosorbent assay microarray assay for distinguishing between blood plasma and serum samples
CN120446474A (zh) 一种小分子的检测方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080228

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080228

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20080228

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080411

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20080526

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080603

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080804

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080916

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080924

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111010

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121010

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141010

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313114

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees